EMD-52477

Single-particle
2.53 Å
EMD-52477
3D View Gallery
Deposition: 07/01/2025
Map released: 22/07/2026
Last modified: 22/07/2026
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-52477

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-9hxh summary report (pdf.gz) Map-9hxh FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

Bacterial antiviral defense protein Ec2ApeA from Escherichia coli strain 2-156-04_S4_C1 co-purified with pdCpdG dinucleotide (HEPN active site mutant R502A)

EMD-52477

Single-particle
2.53 Å
EMD-52477
3D View Gallery
Deposition: 07/01/2025
Map released: 22/07/2026
Last modified: 22/07/2026
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Escherichia coli 2-156-04_S4_C1, Escherichia coli BL21(DE3)
Sample: Bacterial antiviral defense protein Ec2ApeA from Escherichia coli strain 2-156-04_S4_C1 co-purified with pdCpdG dinucleotide (HEPN active site mutant R502A)
Fitted models: 9hxh

Deposition Authors: Sasnauskas G, Juozapaitis J, Puteikiene R, Tamulaitiene G

ApeA is a deoxyribodinucleotide binding antiviral defense system targeting tRNA
Juozapaitis J, Silanskas A, Ruksenaite A, Puteikiene R, Truncaite L, Songailiene I, Tamulaitiene G, Siksnys V, Sasnauskas G
To Be Published
Grant Support: